News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Knopp NeuroSciences Reports Presentation of Encouraging Clinical Trends in a Phase 2 Study of KNS-760704 in ALS


12/9/2009 9:41:20 AM

BERLIN--(BUSINESS WIRE)--Knopp Neurosciences Inc. (“Knopp”) announced the presentation today of encouraging clinical results in a Phase 2 safety and tolerability study of KNS-760704 in amyotrophic lateral sclerosis (“ALS”). The results were presented at the 20th International Symposium on ALS/MND in Berlin, Germany, by Merit Cudkowicz, M.D., Associate Professor of Neurology at the Massachusetts General Hospital of Harvard Medical School.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES